Amendment No. 1 (hereinafter the “Amendment No. 1”) to the Technology Transfer, Clinical Supply Agreement dated October 23, 2012, (hereinafter the “Agreement”)Technology Transfer, Clinical Supply Agreement • February 18th, 2014 • Versartis, Inc. • Pharmaceutical preparations
Contract Type FiledFebruary 18th, 2014 Company IndustryWhereas, the Parties intend on continuing their good relationship and are now desirous to perform additional cGMP fill and finish and drug substance services under the
ContractTechnology Transfer, Clinical Supply Agreement • March 19th, 2014 • Versartis, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 19th, 2014 Company Industry[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
ContractTechnology Transfer, Clinical Supply Agreement • August 7th, 2017 • Versartis, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 7th, 2017 Company Industry[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.